Pricing guide
Why GLP-1 telehealth prices vary so much.
Two GLP-1 telehealth offers can be hundreds of dollars apart per month and still both be legitimate. Before you compare subscription numbers, the five structural reasons below explain where the gap actually comes from — and what each offer is quietly leaving out of its headline.
1. Formulation — what’s actually in the vial.
The single biggest driver of month-to-month price is which molecule is in the syringe. Brand-name semaglutide ships as Ozempic and Wegovy, brand-name tirzepatide as Mounjaro and Zepbound, and both molecules are also available as compounded preparations from licensed partner pharmacies. Tirzepatide prices higher per milligram than semaglutide at every therapeutic dose, so two quotes that look similar at the headline often diverge once you check which molecule they are actually prescribing.
Compounded vs brand semaglutide, on the same line.
A second split sits inside each molecule. Compounded semaglutide is prepared by a partnering pharmacy to a clinician’s prescription; brand-name Ozempic and Wegovy ship from the manufacturer’s own FDA-approved supply chain. Brand is FDA-reviewed for safety and efficacy at scale; compounded GLP-1s are not — they are compounded under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act and ride on a different (and usually lower) cost structure. The compounded vs brand semaglutide decision is yours, but the offer you are comparing must tell you which one you are actually buying.
2. Compounding pathway — 503A vs 503B.
Even after you decide “compounded,” the price still depends on which pharmacy class is filling the vial. A 503A traditional compounding pharmacy prepares the drug for an individual patient on receipt of a valid prescription — dose, sterility, and purity are the pharmacy’s own responsibility, which is why the cost per patient is generally higher. A 503B outsourcing facility operates under stricter, FDA-style manufacturing standards and can produce batches in advance, which is why those offers tend to land lower on the price ladder.
What the regulation does not cover.
Neither 503A nor 503B compounding is an FDA approval route. The product has not been FDA-reviewed for safety, efficacy, or manufacturing quality at the brand-name level, and that fact should sit right next to the lower price on any comparison you run. A quote that quietly blends a compounded product into brand pricing, or that names neither pathway, is one of the GLP-1 telehealth red flags worth walking away from before you pay the first month.
3. Dose tier — the headline ignores month 2 and month 3.
GLP-1 therapy is titrated: the clinician starts you on a low dose, watches your tolerance, and steps you up to the therapeutic dose over the first two or three months. The canonical semaglutide ladder runs 2.5 mg → 5 mg → 7.5 mg → 10 mg → 15 mg, and the analog tirzepatide ladder runs alongside it. Therapeutic doses cost materially more than starting doses, so a “starting at $99” offer quietly turns into a $300 month the moment you reach the dose the clinician actually wants you on.
What to ask before you compare.
Ask every provider what each titration step costs individually, what the recommended maintenance dose is after titration, and how the price changes when you reach it. Two offers can post the same $99 headline and produce wildly different six-month totals purely because their maintenance-dose pricing is structured differently. Compare the all-in monthly cost across the first six months, not the starter-month sticker.
4. Included care — what sits inside the bundle.
The same monthly number can quietly bundle very different clinical services. Some offers include baseline labs (a metabolic panel at minimum) and follow-up labs at three or six months; others hand you a lab order through Quest or LabCorp and bill it separately. Some include unlimited asynchronous clinician messaging, monthly nutrition check-ins, or a registered dietitian session; others sell the consult alone and let you stack the rest on the back end.
Unbundled offers look cheaper; they are not.
An unbundled subscription will almost always post a lower sticker than a bundled one, but once you add the lab work, the follow-up visits, the dietitian, and the price you actually pay for the dose you titrate to, the comparison flips. Verify what is inside the bundle before you compare numbers, and price every add-on a buyer in your situation will actually use. Two offers at $199 and $249 a month can land in either order once the add-on stack is audited.
5. Licensing footprint — who can actually prescribe to you.
The least visible driver of price is the size of the clinician network behind the storefront. A national provider licenses physicians, nurse practitioners, and physician assistants in every state it serves, which costs more to build and run than a regional network that covers, say, twelve states. Some providers go the other direction and hire per-state MDs, DOs, NPs, and PAs on an obvious premium; others deliberately restrict to a small state set and price accordingly. Licensing footprint is part of why the same molecule at the same dose can sit at $199 in one storefront and $349 in another.
Cross-state licensing thread.
The clinician must be licensed in the state where you physically sit during the visit, not the state where the company is incorporated — the same licensing thread that runs through our provider verification guide. Before you pay, confirm the offer covers your state, that the prescribing clinician is named in your account, and that the pharmacy is registered to ship into the address where you will receive the medication. Footprint shows up as a subscription price difference; what it really costs you is whether the offer can complete the checkout flow at all.